Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis

NCT04301752 is registered in ClinicalTrials.gov with Mansoura University Hospital as lead sponsor.

NCT NCT04301752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04301752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis
Lead sponsor
Mansoura University Hospital
Phase
Observational
Overall status
Completed
Start date
February 1, 2019
Completion date
March 1, 2020
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brucellosis